Labiana Health S.A. (LAB) - Total Liabilities
Based on the latest financial reports, Labiana Health S.A. (LAB) has total liabilities worth €50.77 Million EUR (≈ $59.36 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Labiana Health S.A. annual equity growth to track the company's year-over-year net asset growth rate.
Labiana Health S.A. - Total Liabilities Trend (2021–2024)
This chart illustrates how Labiana Health S.A.'s total liabilities have evolved over time, based on quarterly financial data. See Labiana Health S.A. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Labiana Health S.A. Competitors by Total Liabilities
The table below lists competitors of Labiana Health S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
JLS Co.Ltd
KQ:040420
|
Korea | ₩19.77 Billion |
|
Savezone I C
KO:067830
|
Korea | ₩90.66 Billion |
|
Bafna Pharmaceuticals Limited
NSE:BAFNAPH
|
India | Rs753.88 Million |
|
JHM Consolidation Bhd
KLSE:0127
|
Malaysia | RM195.34 Million |
|
Annovis Bio Inc
NYSE:ANVS
|
USA | $4.23 Million |
|
OT Logistics S.A
WAR:OTS
|
Poland | zł536.21 Million |
|
Dish TV India Limited
NSE:DISHTV
|
India | Rs57.40 Billion |
|
Birla Cable Limited
NSE:BIRLACABLE
|
India | Rs1.62 Billion |
Liability Composition Analysis (2021–2024)
This chart breaks down Labiana Health S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Labiana Health S.A..
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.42 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 12.93 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.93 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Labiana Health S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Labiana Health S.A. (2021–2024)
The table below shows the annual total liabilities of Labiana Health S.A. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €49.43 Million ≈ $57.79 Million |
-11.28% |
| 2023-12-31 | €55.72 Million ≈ $65.14 Million |
+5.06% |
| 2022-12-31 | €53.04 Million ≈ $62.00 Million |
-6.70% |
| 2021-12-31 | €56.84 Million ≈ $66.46 Million |
-- |
About Labiana Health S.A.
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms,… Read more